Free Trial
NYSE:ITGR

Integer (ITGR) Stock Price, News & Analysis

$121.34
-1.29 (-1.05%)
(As of 05/28/2024 ET)
Today's Range
$120.80
$123.29
50-Day Range
$109.59
$123.34
52-Week Range
$69.40
$123.99
Volume
286,647 shs
Average Volume
327,379 shs
Market Capitalization
$4.07 billion
P/E Ratio
41.99
Dividend Yield
N/A
Price Target
$128.00

Integer MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.71 Rating Score
Upside/​Downside
5.5% Upside
$128.00 Price Target
Short Interest
Bearish
8.89% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
1.05mentions of Integer in the last 14 days
Based on 8 Articles This Week
Insider Trading
Selling Shares
$1.95 M Sold Last Quarter
Proj. Earnings Growth
16.70%
From $5.27 to $6.15 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.48 out of 5 stars

Medical Sector

477th out of 931 stocks

Electromedical Equipment Industry

10th out of 20 stocks

ITGR stock logo

About Integer Stock (NYSE:ITGR)

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies. In addition, the company offers rechargeable batteries and chargers; and arthroscopic, laparoscopic, and general surgery devices and components, such as harmonic scalpels, shaver blades, burr shavers, radio frequency probes, biopsy probes, trocars, electrocautery components, wound dressings, GERD treatment components, and phacoemulsification needles. Further, it provides orthopedic products that include instruments used in hip, knee, and spine surgeries, as well as reamers and chisels. Additionally, the company offers customized battery power and power management systems, and battery solutions for the energy, military, and environmental markets. Furthermore, the company provides medical technologies. It serves multi-national original equipment manufacturers and their affiliated subsidiaries in the cardiac rhythm management, neuromodulation, orthopedics, vascular, and advanced surgical and portable medical markets. Integer Holdings Corporation was founded in 1970 and is headquartered in Plano, Texas.

ITGR Stock Price History

ITGR Stock News Headlines

Integer (NYSE:ITGR) Price Target Raised to $124.00
Beyond The Numbers: 7 Analysts Discuss Integer Holdings Stock
Integer Holdings (ITGR) Gets a Buy from KeyBanc
Q1 2024 Integer Holdings Corp Earnings Call
See More Headlines
Receive ITGR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Integer and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
4/25/2024
Today
5/28/2024
Next Earnings (Estimated)
7/25/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Electromedical equipment
Sub-Industry
Health Care Equipment
Previous Symbol
NASDAQ:ITGR
CUSIP
39153L10
Employees
10,500
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$128.00
High Stock Price Target
$139.00
Low Stock Price Target
$94.00
Potential Upside/Downside
+4.5%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.71
Research Coverage
7 Analysts

Profitability

Net Income
$90.65 million
Pretax Margin
7.11%

Debt

Sales & Book Value

Annual Sales
$1.63 billion
Cash Flow
$7.93 per share
Book Value
$45.58 per share

Miscellaneous

Free Float
32,834,000
Market Cap
$4.10 billion
Optionable
Optionable
Beta
1.12
7 Stocks to Own Before the 2024 Election Cover

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report

Key Executives

  • Mr. Joseph W. DziedzicMr. Joseph W. Dziedzic (Age 56)
    President, CEO & Director
    Comp: $3.24M
  • Mr. Diron Smith (Age 50)
    Executive VP & CFO
    Comp: $651.22k
  • Mr. McAlister C. Marshall II (Age 54)
    Senior VP, General Counsel, Chief Ethics & Compliance Officer and Corporate Secretary
    Comp: $854.89k
  • Mr. Kirk K. Thor (Age 60)
    Executive VP & Chief Human Resources Officer
    Comp: $791.64k
  • Mr. Payman Khales (Age 54)
    President of Cardio & Vascular
    Comp: $1.14M
  • Mr. John Harris (Age 64)
    Executive Vice President of Global Operations & Manufacturing Strategy
    Comp: $521.18k
  • Mr. Tom P. Thomas (Age 53)
    VP, Corporate Controller & Principal Accounting Officer
  • Mr. Andrew Senn (Age 42)
    Senior Vice President of Strategy, Business Development & Investor Relations
  • Ms. Margaret Carthy (Age 60)
    Executive VP of Global Quality & Regulatory Affairs
  • Mr. Jim Stephens (Age 50)
    President of Cardiac Rhythm Management & Neuromodulation

ITGR Stock Analysis - Frequently Asked Questions

Should I buy or sell Integer stock right now?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Integer in the last year. There are currently 2 hold ratings and 5 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" ITGR shares.
View ITGR analyst ratings
or view top-rated stocks.

What is Integer's stock price target for 2024?

7 analysts have issued 12 month target prices for Integer's stock. Their ITGR share price targets range from $94.00 to $139.00. On average, they expect the company's share price to reach $128.00 in the next twelve months. This suggests a possible upside of 5.5% from the stock's current price.
View analysts price targets for ITGR
or view top-rated stocks among Wall Street analysts.

How have ITGR shares performed in 2024?

Integer's stock was trading at $99.08 at the beginning of the year. Since then, ITGR shares have increased by 22.5% and is now trading at $121.34.
View the best growth stocks for 2024 here
.

Are investors shorting Integer?

Integer saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 2,810,000 shares, an increase of 9.3% from the April 15th total of 2,570,000 shares. Based on an average daily volume of 379,000 shares, the days-to-cover ratio is currently 7.4 days. Approximately 8.5% of the shares of the company are sold short.
View Integer's Short Interest
.

When is Integer's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, July 25th 2024.
View our ITGR earnings forecast
.

How were Integer's earnings last quarter?

Integer Holdings Co. (NYSE:ITGR) announced its earnings results on Thursday, April, 25th. The medical equipment provider reported $1.14 earnings per share for the quarter, beating the consensus estimate of $1.12 by $0.02. The medical equipment provider had revenue of $414.80 million for the quarter, compared to the consensus estimate of $412.78 million. Integer had a trailing twelve-month return on equity of 11.25% and a net margin of 6.01%. Integer's revenue for the quarter was up 9.5% compared to the same quarter last year. During the same period in the prior year, the company posted $0.87 EPS.

What guidance has Integer issued on next quarter's earnings?

Integer issued an update on its FY 2024 earnings guidance on Thursday, April, 25th. The company provided earnings per share guidance of 5.010-5.430 for the period, compared to the consensus EPS estimate of 5.310. The company issued revenue guidance of $1.7 billion-$1.8 billion, compared to the consensus revenue estimate of $1.8 billion.

What is Joseph Dziedzic's approval rating as Integer's CEO?

40 employees have rated Integer Chief Executive Officer Joseph Dziedzic on Glassdoor.com. Joseph Dziedzic has an approval rating of 86% among the company's employees.

What other stocks do shareholders of Integer own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Integer investors own include Abbott Laboratories (ABT), Pfizer (PFE), Procter & Gamble (PG), Gilead Sciences (GILD), Coca-Cola (KO), AT&T (T), AbbVie (ABBV), Advanced Micro Devices (AMD), Cisco Systems (CSCO) and General Mills (GIS).

Who are Integer's major shareholders?

Integer's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (11.42%), Earnest Partners LLC (3.50%), Silvercrest Asset Management Group LLC (2.53%), Congress Asset Management Co. MA (1.36%), William Blair Investment Management LLC (0.88%) and Tributary Capital Management LLC (0.85%). Insiders that own company stock include Andrew Senn, Anthony W Borowicz, Bill R Sanford, Bill R Sanford, Carter Houghton, Donald J Spence, James F Hinrichs, Jean M Hobby, John A Harris, Joseph F Flanagan, Joseph W Dziedzic, Pamela G Bailey and Tommy P Thomas.
View institutional ownership trends
.

How do I buy shares of Integer?

Shares of ITGR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:ITGR) was last updated on 5/29/2024 by MarketBeat.com Staff

From Our Partners